diabetes coronary artery disease pathophysiology

Báo cáo y học: "Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turk

Báo cáo y học: "Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turk

... Abbreviations: Cx, left circumflex coronary artery; LAD, left ante- rior descending coronary artery; LVEF, left ventricular ejection fraction; RCA, right coronary artery. a Indicates patients who ... J. Med. Sci. 2011, 8 http://www.medsci.org 69 (BMSs) in patients with symptomatic coronary artery disease of simple to moderate complexity (1-3). The use of the Zotarolimus-eluting stent ... 14. Ellis SG, Vandormael MG, Cowley MJ. Coronary morphologic and clinical determinants of procedural outcome with angiop- lasty for multivessel coronary disease: implications for patient selection....

Ngày tải lên: 25/10/2012, 11:18

6 550 0
Báo cáo y học: "Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey&

Báo cáo y học: "Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey&

... Abbreviations: Cx, left circumflex coronary artery; LAD, left anterior descending coronary artery; LVEF, left ventricular ejection fraction; RCA, right coronary artery. a Indicates patients who ... better long-term safety and efficacy than the PES in unselected Turkish patients with coronary artery disease. However, despite our study and several others in which the SES and the PES have ... C, Mann JT, Turco M, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231 3. Valgimigli M, van Mieghem CA, Ong AT, Aoki J,...

Ngày tải lên: 26/10/2012, 08:57

6 628 0
Coronary Artery Disease – New Insights and Novel Approaches Edited by Angelo Squeri pdf

Coronary Artery Disease – New Insights and Novel Approaches Edited by Angelo Squeri pdf

... 1 Pathogenesis Coronary Artery Disease – New Insights and Novel Approaches 28 3.6 Gene-gene and gene-environmental interaction in manifestation of coronary artery disease The fact that ... influencing various aspects of coronary artery function and structure with prevalent genetic factors. Coronary Artery Disease – New Insights and Novel Approaches 26 the disease. Plasma leptin ... surrounding network with blood supply. 2. What causes coronary artery disease? Since coronary arteries deliver blood to the heart muscle, disease can have serious implications by reducing the...

Ngày tải lên: 08/03/2014, 00:20

270 931 0
báo cáo hóa học:" Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study" potx

báo cáo hóa học:" Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study" potx

... TXB 2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study Andreas C Eriksson* 1 , Lena Jonasson 2 , Tomas L ... http://www.translational-medicine.com/content/7/1/42 Page 7 of 14 (page number not for citation purposes) Comparisons between patients with coronary artery disease and controls The factors were further analysed by One-sample t-test for differences ... controls at two separate occasions (Figure 2). Effects of platelet inhibiting treatment in coronary artery disease When investigating possible effects of platelet-inhibiting treatment with Repeated...

Ngày tải lên: 18/06/2014, 15:20

14 521 0
báo cáo hóa học: " Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey" ppt

báo cáo hóa học: " Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey" ppt

... [3,4]. Patients with coronary artery disease (CAD) and refrac- tory or recurrent retrosternal symptoms have a reduction in life expectancy and HRQL compared to patients w ith stable coronary artery disease ... Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010, 363:1909-17. 43. Juurlink DN: Clopidogrel with or without omeprazole in coronary disease. N Engl J Med 2011, 364:681-2. 44. ... more effectively than the placebo. List of abbreviations HRQL: health-related quality of life; CAD: coronary artery disease; GER: gastroesophageal reflux; PPI: proton pump inhibitors; HRQLRAD: Quality of Life...

Ngày tải lên: 20/06/2014, 15:20

9 483 0
Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease pot

Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease pot

... atherosclerosis. What about cardiovascular disease? The immu- nomodulatory effects of statins in various autoim- mune diseases apply equally well to cardiovascu- lar disease, in which surprisingly similar ... patients with heart fail- ure and left ventricular systolic dysfunction attri- buted to coronary artery disease. The study, called the Controlled Rosuvastatin Multinational Trial in Heart Failure ... reconciled with the existing randomized trials of statins in patients with es- tablished coronary artery disease? First, statins as a class may not be efficacious in patients with ischemic left...

Ngày tải lên: 27/06/2014, 00:20

18 315 0
Angiotensin-Converting– Enzyme Inhibition in Stable Coronary Artery Disease potx

Angiotensin-Converting– Enzyme Inhibition in Stable Coronary Artery Disease potx

... 56 Coronary disease on angiography 61 61 Angina pectoris 70 71 Percutaneous coronary intervention 42 41 Coronary- artery bypass grafting 38 40 Percutaneous coronary intervention or coronary- artery ... with vascular disease who do not have overt heart failure reduces the risk of major atherosclerotic events. In HOPE, high-risk patients with vascular disease (in- cluding coronary artery disease) or diabetes ... of Cardiac Events with Perindopril in Stable Coronary Artery Disease (EUROPA), 16 pa- tients with coronary or other vascular disease or with diabetes and another cardiovascular risk fac- tor...

Ngày tải lên: 27/06/2014, 00:20

15 285 0
w